You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 144 No. 2, February 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Increased Airway Leukotriene Levels in Infants With Severe Bronchopulmonary Dysplasia

Robert Mirro, MD; William Armstead, PhD; Charles Leffler, PhD

Am J Dis Child. 1990;144(2):160-161.


Abstract

• The sulphidopeptide leukotrienes (C4, D4, and E4) are potent airway constrictors that have been detected in the airways of infants with pulmonary hypertension and viral infections. The present study was undertaken to test the hypothesis that leukotrienes in tracheal lavage fluid are elevated in bronchopulmonary dysplasia. Twenty-six intubated infants (10 with bronchopulmonary dysplasia, 9 with hyaline membrane disease, and 7 normal controls) had tracheal lavage leukotriene levels determined by radioimmunoassay. Lavage fluid cell counts (alveolar macrophages) and leukotriene levels were significantly increased in infants with severe bronchopulmonary dysplasia. The increased concentration of leukotrienes seen in the infants with bronchopulmonary dysplasia would suggest a possible role for these compounds in the pathophysiology of this disease.

(AJDC. 1990;144:160-161)



Author Affiliations

From the Departments of Pediatrics (Drs Mirro and Leffler), Obstetrics and Gynecology (Dr Mirro), Physiology and Biophysics (Drs Mirro, Leffler, and Armstead), University of Tennessee, Memphis.


Footnotes

Accepted for publication August 30, 1989.

Reprint requests to Newborn Center, 853 Jefferson Ave, Room 201, Memphis, TN 38163 (Dr Mirro).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Statement on the Care of the Child with Chronic Lung Disease of Infancy and Childhood
Am. J. Respir. Crit. Care Med. 2003;168:356-396.
FULL TEXT  

Urinary Leukotriene E4 Excretion During the First Month of Life and Subsequent Bronchopulmonary Dysplasia in Premature Infants
Sheikh et al.
Chest 2001;119:1749-1754.
ABSTRACT | FULL TEXT  

Leukotriene Modifiers in Pediatric Asthma Management
Bisgaard
Pediatrics 2001;107:381-390.
ABSTRACT | FULL TEXT  

Prediction of individual response to postnatal dexamethasone in ventilator dependent preterm infants
Kuschel et al.
Arch. Dis. Child. Fetal Neonatal Ed. 1998;78:199F-203.
ABSTRACT | FULL TEXT  

ELEVATED LEUKOTRIENE LEVELS IN BRONCHOPULMONARY DYSPLASIA
JWatch General 1990;1990:6-6.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.